• Abdulkarim AS, Petrovic LM, Kim WR, Angulo P, Lloyd RV, Lindor KD 2004 Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae? J. Hepatol. 40: 380-384. *

• Ahdoot A, Kotler DP, Suh JS, Kutler C, Flamholz R 2006 Lymphogranuloma venereum in human immunodeficiency virus-infected individuals in New York city. J. Clin. Gastroenterol. 40: 385-390.

• Ajonuma LC, He Q, Sheung Chan PK, Yu Ng EH, Fok KL, Yan Wong CH, Tsang LL, Ho LS, Lau MC, Huang HY, Yang DZ, Rowlands DK, Tang XX, Zhang XH, Chung YW, Chan HC 2008 Involvement of cystic fibrosis transmembrane conductance regulator in infection-induced edema. Cell Biol. Int. 32: 801-806. *

• Appel H, Kuon W, Kuhne M, Wu P, Kuhlmann S, Kollnberger S, Thiel A, Bowness P, Sieper J 2004 Use of HLA-B27 tetramers to identify low-frequency antigen-specific T cells in Chlamydia-triggered reactive arthritis. Arthritis Res. Ther. 6: R521-R534. *

• Ausiello CM, Fedele G, Palazzo R, Spensieri F, Ciervo A, Cassone A 2006 60-kDa heat shock protein of Chlamydia pneumoniae promotes a T helper type 1 immune response through IL-12/IL-23 production in monocyte-derived dendritic cells. Microbes Infect. 8: 714-720. *

• Bachmaier K, Penninger JM 2005 Chlamydia and antigenic mimicry. Curr. Top. Microbiol. Immunol. 296: 153-163.

• Bagos PG, Nikolopoulos G, Ioannidis A 2006 Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis. Mult. Scler. 12: 397-411.

• Bas S, Neff L, Vuillet M, Spenato U, Seya T, Matsumoto M, Gabay C 2008 The proinflammatory cytokine response to Chlamydia trachomatis elementary bodies in human macrophages is partly mediated by a lipoprotein, the macrophage infectivity potentiator, through TLR2/TLR1/TLR6 and CD14. J. Immunol. 180: 1158-1168.

• Bergasa NV, Mason A, Floreani A, Heathcote J, Swain MG, Jones DE, Lindor KM, Bassendine MF, Worman HJ 2004 Primary biliary cirrhosis: report of a focus study group. Hepatology 40: 1013-1020. *

• Bernstein-Hanley I, Balsara ZR, Ulmer W, Coers J, Starnbach MN, Dietrich WF 2006 Genetic analysis of susceptibility to Chlamydia trachomatis in mouse. Genes Immun. 7: 122-129. *

• Blasi C 2004 The role of the infectious agents in the pathogenesis and evolution of atherosclerosis. Ann. Ital. Med. Int. 19: 249-261.

• Bogdanos DP, Vergani D 2008 Bacteria and primary biliary cirrhosis. Clin. Rev. Allergy Immunol. May 23 [Epub ahead of print].

• Bouwman JJ, Visseren FL, Bouter KP, Diepersloot RJ 2008 Infection-induced inflammatory response of adipocytes in vitro. Int. J. Obes. (Lond.) 32: 892-901. *

• Bowness P 2002 HLA B27 in health and disease: a double-edged sword? Rheumatology (Oxford) 41: 857-868. *

• Brunham RC, Rey-Ladino J 2005 Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat. Rev. Immunol. 5: 149-161. *

• Buchholz KR, Stephens RS 2008 The cytosolic pattern recognition receptor NOD1 induces inflammatory IL-8 during C. trachomatis infection. Infect. Immun. 76: 3150-3155. *

• Butrimiene I, Ranceva J, Griskevicius A 2006 Potential triggering infections of reactive arthritis. Scand. J. Rheumatol. 35: 459-462.

• Cao F, Castrillo A, Tontonoz P, Re F, Byrne GI 2007 Chlamydia pneumoniae-induced macrophage foam cell formation is mediated by Toll-like receptor 2. Infect. Immun. 75: 753-759. *

• Carter JD, Gerard HC, Hudson AP 2008 Psoriasiform lesions induced by TNF antagonists: a skin-deep medical conundrum. Ann. Rheum. Dis. 67: 1181-1183.

• Carter JD, Valeriano J, Vasey FB 2004 Doxycycline versus doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to Chlamydia-induced arthritis. A prospective, randomized 9-month comparison. J. Rheumatol. 31: 1973-1980.

• Chang HK, Bang KT, Lee BH, Kim JH, Bae KW, Kim MJ, Kim SK 2006 Concurrence of Sjogren's syndrome in a patient with Chlamydia-induced reactive arthritis; an unusual finding. Korean J. Intern. Med. 21: 116-119.

• Chao YL, Shen YC, Liao DL, Chen JY, Wang YC, Lai IC, Liou YJ, Chen CH 2008 Association study of HLA-A gene and schizophrenia in Han Chinese from Taiwan. Prog. Neuropsychopharmacol. Biol. Psychiatry Aug 23 [Epub ahead of print].

• Chapman RW 2003 Viruses, protozoans and drugs as etiological factors in primary sclerosing cholangitis. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 73-74. October 15-16. *

• Clifton IJ, Kastelik JA, Peckham DG, Hale A, Denton M, Etherington C, Conway SP 2008 Ten years of viral and non-bacterial serology in adults with cystic fibrosis. Epidemiol. Infect. 136: 128-134.

• Cragnolini JJ, Lopez de Castro JA 2008 Identification of endogenously presented peptides from Chlamydia trachomatis with high homology to human proteins and to a natural self-ligand of HLA-B27. Mol. Cell. Proteomics 7: 170-180. *

• Da Costa CU, Wantia N, Kirschning CJ, Busch DH, Rodriguez N, Wagner H, Miethke T 2004 Heat shock protein 60 from Chlamydia pneumoniae elicits an unusual set of inflammatory responses via Toll-like receptor 2 and 4 in vivo. Eur. J. Immunol. 34: 2874. *

• Dai W, Gupta SL 1990 Regulation of indoleamine 2,3-dioxygenase gene expression in human fibroblasts by interferon-gamma. Upstream control region discriminates between interferon-gamma and interferon-alpha. J. Biol. Chem. 265: 19871-19877. *

• De Hertogh G, Geboes K 2004 Crohn's disease and infections: a complex relationship. MedGenMed. 6: 14.

• Donati M, Di Francesco A, Gennaro R, Benincasa M, Magnino S, Pignanelli S, Shurdhi A, Moroni A, Mazzoni C, Merialdi G, Baldelli R, Cevenini R 2007 Sensitivity of Chlamydia suis to cathelicidin peptides. Vet. Microbiol. 123: 269-273. *

• Droemann D, Rupp J, Goldmann T, Uhlig U, Branscheid D, Vollmer E, Kujath P, Zabel P, Dalhoff K 2007 Disparate innate immune responses to persistent and acute Chlamydia pneumoniae infection in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 175: 791-797. *

• Eng HL, Wang CH, Chen CH, Chou MH, Cheng CT, Lin TM 2004 A CD14 promoter polymorphism is associated with CD14 expression and Chlamydia-stimulated TNF alpha production. Genes Immun. 5: 426-430. *

• Erridge C, Pridmore A, Eley A, Stewart J, Poxton IR 2004 Lipopolysaccharides of Bacteroides fragilis, Chlamydia trachomatis and Pseudomonas aeruginosa signal via Toll-like receptor 2. J. Med. Microbiol. 53: 735-740. *

• Erridge C, Stewart J, Poxton IR 2003 Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling. J. Exp. Med. 197: 1787-1791. *

• Fainardi E, Castellazzi M, Seraceni S, Granieri E, Contini C 2008 Under the microscope: focus on Chlamydia pneumoniae infection and multiple sclerosis. Curr. Neurovasc. Res. 5: 60-70.

• Ford PJ, Gemmell E, Timms P, Chan A, Preston FM, Seymour GJ 2007 Anti-P. gingivalis response correlates with atherosclerosis. J. Dent. Res. 86: 35-40.

• Forrester B, Pawade J, Horner P 2006 The potential role of serology in diagnosing chronic lymphogranuloma venereum (LGV): a case of LGV mimicking Crohn's disease. Sex. Transm. Infect. 82: 139-140.

• Gajinov Z, Prcic S, Matic M, Duran V, Ivkov-Simic M 2006 Papular-purpuric gloves and socks syndrome - a case report. Med. Pregl. 59: 380-383.

• Girschick HJ, Guilherme L, Inman RD, Latsch K, Rihl M, Sherer Y, Shoenfeld Y, Zeidler H, Arienti S, Doria A 2008 Bacterial triggers and autoimmune rheumatic diseases. Clin. Exp. Rheumatol. 26: S12-S17.

• Grotenbreg GM, Roan NR, Guillen E, Meijers R, Wang JH, Bell GW, Starnbach MN, Ploegh HL 2008 Discovery of CD8+ T cell epitopes in Chlamydia trachomatis infection through use of caged class I MHC tetramers. Proc. Natl. Acad. Sci. U.S.A. 105: 3831-3836. *

• Hannu T, Inman R, Granfors K, Leirisalo-Repo M 2006 Reactive arthritis or post-infectious arthritis? Best Pract. Res. Clin. Rheumatol. 20: 419-433.

• Hansen J, Jensen KT, Follmann F, Agger EM, Theisen M, Andersen P 2008 Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital Chlamydial infection in a mouse model. J. Infect. Dis. 198: 758-767. *

• Hjelle JT, Miller-Hjelle MA, Poxton IR, Kajander EO, Ciftcioglu N, Jones ML, Caughey RC, Brown R, Millikin PD, Darras FS 2000 Endotoxin and nanobacteria in polycystic kidney disease. Kidney Int. 57: 2360-2374. *

• Horn M, Collingro A, Schmitz-Esser S, Beier CL, Purkhold U, Fartmann B, Brandt P, Nyakatura GJ, Droege M, Frishman D, Rattei T, Mewes HW, Wagner M 2004 Illuminating the evolutionary history of chlamydiae. Science 304: 728-730. *

• James SP, Strober W, Quinn TC, Danovitch SH 1987 Crohn's disease. New concepts of pathogenesis and current approaches to treatment. Dig. Dis. Sci. 32: 1297-1310.

• Jiang SJ, Campbell LA, Berry MW, Rosenfeld ME, Kuo CC 2008 Retinoic acid prevents Chlamydia pneumoniae-induced foam cell development in a mouse model of atherosclerosis. Microbes Infect. Jul 17 [Epub ahead of print]. *

• Joyee AG, Yang X 2008 Role of Toll-like receptors in immune responses to chlamydial infections. Curr. Pharm. Des. 14: 593-600.

• Kaplan MM 2004 Novosphingobium aromaticivorans: a potential initiator of primary biliary cirrhosis. Am. J. Gastroenterol. 99: 2147-2149. *

• Khan MA 2002 Update on spondyloarthropathies. Ann. Intern. Med. 136: 896-907. *

• Kitumnuaypong T, Scalzi LV, Nalbant S, Von Feldt JM, Schumacher HR Jr 2004 Is there a role for Chlamydia pneumoniae infection in systemic lupus erythematosus and in the associated atherosclerotic cardiovascular disease? Clin. Exp. Rheumatol. 22: 339-342.

• Koga T, Miyashita T, Watanabe T, Imadachi S, Osumi M, Sakito S, Kuga T, Eguchi K, Migita K 2008 Reactive arthritis which occurred one year after acute chlamydial urethritis. Intern. Med. 47: 663-666. *

• Kuon W, Holzhutter HG, Appel H, Grolms M, Kollnberger S, Traeder A, Henklein P, Weiss E, Thiel A, Lauster R, Bowness P, Radbruch A, Kloetzel PM, Sieper J 2001 Identification of HLA-B27-restricted peptides from the Chlamydia trachomatis proteome with possible relevance to HLA-B27-associated diseases. J. Immunol. 167: 4738-4746. *

• Kuon W, Lauster R, Bottcher U, Koroknay A, Ulbrecht M, Hartmann M, Grolms M, Ugrinovic S, Braun J, Weiss EH, Sieper J 1997 Recognition of chlamydial antigen by HLA-B27-restricted cytotoxic T cells in HLA-B*2705 transgenic CBA (H-2k) mice. Arthritis Rheum. 40: 945-954.

• Leung PS, Park O, Matsumura S, Ansari AA, Coppel RL, Gershwin ME 2003 Is there a relation between Chlamydia infection and primary biliary cirrhosis? Clin. Dev. Immunol. 10: 227-233. *

• Lindholt JS, Shi GP 2006 Chronic inflammation, immune response, and infection in abdominal aortic aneurysms. Eur. J. Vasc. Endovasc. Surg. 31: 453-463.

• Lindholt JS, Stovring J, Ostergaard L, Urbonavicius S, Henneberg EW, Honore B, Vorum H 2004 Serum antibodies against Chlamydia pneumoniae outer membrane protein cross-react with the heavy chain of immunoglobulin in the wall of abdominal aortic aneurysms. Circulation 109: 2097-2102. *

• Liu HY, Deng AM, Zhang J, Zhou Y, Yao DK, Tu XQ, Fan LY, Zhong RQ 2005 Correlation of Chlamydia pneumoniae infection with primary biliary cirrhosis. World J. Gastroenterol. 11: 4108-4110. *

• Liu HY, Fan LY, Tu XQ, Zhou Y, Chen Y, Deng AM, Zhong RQ 2004 The relationship between Chlamydia pneumoniae infection and primary biliary cirrhosis. Zhonghua Gan Zang Bing Za Zhi 12: 546-548.

• Lotz G, Simon S, Patonai A, Sotonyi P, Nemes B, Sergi C, Glasz T, Fule T, Nashan B, Schaff Z 2004 Detection of Chlamydia pneumoniae in liver transplant patients with chronic allograft rejection. Transplantation 77: 1522-1528.

• Maddala YK, Jorgensen RA, Angulo P, Lindor KD 2004 Open-label pilot study of tetracycline in the treatment of primary biliary cirrhosis. Am. J. Gastroenterol. 99: 566-567. *

• Mamata Y, Hakki A, Yamamoto Y, Newton C, Klein TW, Pross S, Friedman H 2005 Nicotine modulates cytokine production by Chlamydia pneumoniae infected human peripheral blood cells. Int. Immunopharmacol. 5: 749-756.

• Marangoni A, Donati M, Cavrini F, Aldini R, Accardo S, Sambri V, Montagnani M, Cevenini R 2006 Chlamydia pneumoniae replicates in Kupffer cells in mouse model of liver infection. World J. Gastroenterol. 12: 6453-6457. *

• Matthews N, Mayberry JF, Rhodes J, Neale L, Munro J, Wensinck F, Lawson GH, Rowland AC, Berkhoff GA, Barthold SW 1980 Agglutinins to bacteria in Crohn's disease. Gut 21: 376-380. *

• Moalem S, Weinberg ED, Percy ME 2004 Hemochromatosis and the enigma of misplaced iron: implications for infectious disease and survival. Biometals 17: 135-139.

• Montano-Loza A, Vazquez-Ballesteros E, Meza-Junco J, Villalobos-Zapata I, Olivera-Martinez M 2006 Seropositivity for Chlamydia pneumoniae in patients with primary biliary cirrhosis. Gastroenterol. Hepatol. 29: 113-117.

• Muller S, Arni S, Varga L, Balsiger B, Hersberger M, Maly F, Seibold F 2006 Serological and DNA-based evaluation of Chlamydia pneumoniae infection in inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 18: 889-894.

• Nagy A, Kozma GT, Keszei M, Treszl A, Falus A, Szalai C 2003 The development of asthma in children infected with Chlamydia pneumoniae is dependent on the modifying effect of mannose-binding lectin. J. Allergy Clin. Immunol. 112: 729-734. *

• Natividad A, Hanchard N, Holland MJ, Mahdi OS, Diakite M, Rockett K, Jallow O, Joof HM, Kwiatkowski DP, Mabey DC, Bailey RL 2007 Genetic variation at the TNF locus and the risk of severe sequelae of ocular Chlamydia trachomatis infection in Gambians. Genes Immun. 8: 288-295. *

• Natividad A, Wilson J, Koch O, Holland MJ, Rockett K, Faal N, Jallow O, Joof HM, Burton MJ, Alexander ND, Kwiatkowski DP, Mabey DC, Bailey RL 2005 Risk of trachomatous scarring and trichiasis in Gambians varies with SNP haplotypes at the interferon-gamma and interleukin-10 loci. Genes Immun. 6: 332-340. *

• Nausheen S, Cunha BA 2007 Q Fever community-acquired pneumonia in a patient with Crohn's disease on immunosuppressive therapy. Heart Lung 36: 300-303.

• Nelson DE, Virok DP, Wood H, Roshick C, Johnson RM, Whitmire WM, Crane DD, Steele-Mortimer O, Kari L, McClarty G, Caldwell HD 2005 Chlamydial IFN-gamma immune evasion is linked to host infection tropism. Proc. Natl. Acad. Sci. U.S.A. 102: 10658-10663. *

• Nickerson CL, Luthra HS, David CS 1990 Role of enterobacteria and HLA-B27 in spondyloarthropathies: studies with transgenic mice. Ann. Rheum. Dis. 49: 426-433.

• Ohman H, Tiitinen A, Halttunen M, Birkelund S, Christiansen G, Koskela P, Lehtinen M, Paavonen J, Surcel HM 2006 IL-10 polymorphism and cell-mediated immune response to Chlamydia trachomatis. Genes Immun. 7: 243-249. *

• Onal S, Kazokoglu H, Incili B, Demiralp EE, Yavuz S 2006 Prevalence and levels of serum antibodies to gram negative microorganisms in Turkish patients with HLA-B27 positive acute anterior uveitis and controls. Ocul. Immunol. Inflamm. 14: 293-299.

• Opitz B, Forster S, Hocke AC, Maass M, Schmeck B, Hippenstiel S, Suttorp N, Krull M 2005 Nod1-mediated endothelial cell activation by Chlamydophila pneumoniae. Circ. Res. 96: 319-326. *

• Otasevic L, Zlatanovic G, Stanojevic-Paovic A, Miljkovic-Selimovic B, Dinic M, Djordjevic-Jocic J, Stankovic A 2007 Helicobacter pylori: an underestimated factor in acute anterior uveitis and spondyloarthropathies? Ophthalmologica 221: 6-13.

• Ozgul A, Dede I, Taskaynatan MA, Aydogan H, Kalyon TA 2006 Clinical presentations of chlamydial and non-chlamydial reactive arthritis. Rheumatol. Int. 26: 879-885. *

• Pacchiarotti A, Sbracia M, Mohamed MA, Frega A, Pacchiarotti A, Espinola SM, Aragona C 2008 Autoimmune response to Chlamydia trachomatis infection and in vitro fertilization outcome. Fertil. Steril. Mar 11 [Epub ahead of print].

• Paguirigan AM, Byrne GI, Becht S, Carlin JM 1994 Cytokine-mediated indoleamine 2,3-dioxygenase induction in response to Chlamydia infection in human macrophage cultures. Infect. Immun. 62: 1131-1136. *

• Palikhe A, Lokki ML, Saikku P, Leinonen M, Paldanius M, Seppänen M, Valtonen V, Nieminen MS, Sinisalo J 2008 Chlamydia pneumoniae infection is associated with HLA-B*35 in patients with coronary artery disease. Clin. Vaccine Immunol. 15: 55-59. *

• Penttinen MA, Ekman P, Granfors K 2004 Non-antigen presenting effects of HLA-B27. Curr. Mol. Med. 4: 41-49.

• Perschinka H, Mayr M, Millonig G, Mayerl C, van der Zee R, Morrison SG, Morrison RP, Xu Q, Wick G 2003 Cross-reactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 23: 1060-1065.

• Ponsioen CY, Defoer J, Ten Kate FJ, Weverling GJ, Tytgat GN, Pannekoek Y, Wertheim-Dillen PM 2002 A survey of infectious agents as risk factors for primary sclerosing cholangitis: are Chlamydia species involved? Eur. J. Gastroenterol. Hepatol. 14: 641-648.

• Posnett DN, Yarilin D 2005 Amplification of autoimmune disease by infection. Arthritis Res. Ther. 7: 74-84. *

• Puolakkainen M, Lee A, Nosaka T, Fukushi H, Kuo CC, Campbell LA 2008 Retinoic acid inhibits the infectivity and growth of Chlamydia pneumoniae in epithelial and endothelial cells through different receptors. Microb. Pathog. 44: 410-416. *

• Putschky N, Pott HG, Kuipers JG, Zeidler H, Hammer M, Wollenhaupt J 2006 Comparing 10-day and 4-month doxycycline courses for treatment of Chlamydia trachomatis-reactive arthritis: a prospective, double-blind trial. Ann. Rheum. Dis. 65: 1521-1524. *

• Rihl M, Zeidler H 2007 The molecular pathogenesis of Chlamydia-induced arthritis: where do we stand? Curr. Rheumatol. Rep. 9: 4-5.

• Rodel J, Groh A, Hartmann M, Schmidt KH, Lehmann M, Lungershausen W, Straube E 1999 Expression of interferon regulatory factors and indoleamine 2,3-dioxygenase in Chlamydia trachomatis-infected synovial fibroblasts. Med. Microbiol. Immunol. 187: 205-212.

• Rodriguez N, Mages J, Dietrich H, Wantia N, Wagner H, Lang R, Miethke T 2007 MyD88-dependent changes in the pulmonary transcriptome after infection with Chlamydia pneumoniae. Physiol. Genomics 30: 134-145. *

• Rudwaleit M, Braun J, Sieper J 2000 Treatment of reactive arthritis: a practical guide. BioDrugs 13: 21-28.

• Rugonfalvi-Kiss S, Endresz V, Madsen HO, Burian K, Duba J, Prohaszka Z, Karadi I, Romics L, Gonczol E, Fust G, Garred P 2002 Association of Chlamydia pneumoniae with coronary artery disease and its progression is dependent on the modifying effect of mannose-binding lectin. Circulation 106: 1071-1076. *

• Rupp J, Goepel W, Kramme E, Jahn J, Solbach W, Maass M 2004 CD14 promoter polymorphism -159C>T is associated with susceptibility to chronic Chlamydia pneumoniae infection in peripheral blood monocytes. Genes Immun. 5: 435-438. *

• Seiderer J, Ochsenkuhn T 2006 Reaching out for the causative agent in inflammatory bowel disease: is there evidence for Chlamydia pneumoniae as a pathogenic factor? Eur. J. Gastroenterol. Hepatol. 18: 875-876.

• Shirey KA, Jung JY, Carlin JM 2006 Up-regulation of interferon-gamma receptor expression due to Chlamydia-Toll-like receptor interaction does not enhance STAT-1 signaling. Infect. Immun. 74: 6877-6884. *

• Sieper J 2004 Disease mechanisms in reactive arthritis. Curr. Rheumatol. Rep. 6: 110-116.

• Siewert K, Rupp J, Klinger M, Solbach W, Gieffers J 2005 Growth cycle-dependent pharmacodynamics of antichlamydial drugs. Antimicrob. Agents Chemother. 49: 1852-1856. *

• Sigal LH 2005 Basic science for the clinician 27: Toll-like receptors and nucleotide oligomerization domains. J. Clin. Rheumatol. 11: 176-179.

• Stratton CW, Wheldon DB 2006 Multiple sclerosis: an infectious syndrome involving Chlamydophila pneumoniae. Trends Microbiol. 14: 474-479. *

• Swanborg RH, Boros DL, Whittum-Hudson JA, Hudson AP 2006 Molecular mimicry and horror autotoxicus: do chlamydial infections elicit autoimmunity? Expert Rev. Mol. Med. 8: 1-23.

• Szczucinski A, Losy J 2006 Infectious agents in the pathogenesis of multiple sclerosis. Przegl. Epidemiol. 60 Suppl. 1: 160-165.

• Sziller I, Babula O, Ujhazy A, Nagy B, Hupuczi P, Papp Z, Linhares IM, Ledger WJ, Witkin SS 2007 Chlamydia trachomatis infection, Fallopian tube damage and a mannose-binding lectin codon 54 gene polymorphism. Hum. Reprod. 22: 1861-1865.

• Taylor-Robinson D, Sharif AW, Dhanjal NS, Taylor-Robinson SD 2005 Chlamydia pneumoniae infection is an unlikely cause of primary biliary cirrhosis. J. Hepatol. 42: 779-780. *

• Telyatnikova N, Hill Gaston JS 2006 Prior exposure to infection with Chlamydia pneumoniae can influence the T-cell-mediated response to Chlamydia trachomatis. FEMS Immunol. Med. Microbiol. 47: 190-198. *

• Tinmouth J, Rachlis A, Wesson T, Hsieh E 2006 Lymphogranuloma venereum in North America: case reports and an update for gastroenterologists. Clin. Gastroenterol. Hepatol. 4: 469-473.

• Triantafilou M, Gamper FG, Lepper PM, Mouratis MA, Schumann C, Harokopakis E, Schifferle RE, Hajishengallis G, Triantafilou K 2007 Lipopolysaccharides from atherosclerosis-associated bacteria antagonize TLR4, induce formation of TLR2/1/CD36 complexes in lipid rafts and trigger TLR2-induced inflammatory responses in human vascular endothelial cells. Cell. Microbiol. 9: 2030-2039. *

• Ugrinovic S, Mertz A, Wu P, Braun J, Sieper J 1997 A single nonamer from the Yersinia 60-kDa heat shock protein is the target of HLA-B27-restricted CTL response in Yersinia-induced reactive arthritis. J. Immunol. 159: 5715-5723.

• Van Kruiningen HJ, Mayo DR, Vanopdenbosch E, Gower-Rousseau C, Cortot A, Colombel JF 2000 Virus serology in familial Crohn disease. Scand. J. Gastroenterol. 35: 403-407. *

• Virok DP, Nelson DE, Whitmire WM, Crane DD, Goheen MM, Caldwell HD 2005 Chlamydial infection induces pathobiotype-specific protein tyrosine phosphorylation in epithelial cells. Infect. Immun. 73: 1939-1946. *

• Wagenlehner FM, Weidner W, Naber KG 2006 Chlamydial infections in urology. World J. Urol. 24: 4-12. *

• Wakefield D, Easter J, Robinson P, Graham D, Penny R 1986 Chlamydial antibody crossreactivity with peripheral blood mononuclear cells of patients with ankylosing spondylitis: the role of HLA B27. Clin. Exp. Immunol. 63: 49-57. *

• Weber P, Koch M, Heizmann WR, Scheurlen M, Jenss H, Hartmann F 1992 Microbic superinfection in relapse of inflammatory bowel disease. J. Clin. Gastroenterol. 14: 302-308.

• Welter-Stahl L, Ojcius DM, Viala J, Girardin S, Liu W, Delarbre C, Philpott D, Kelly KA, Darville T 2006 Stimulation of the cytosolic receptor for peptidoglycan, Nod1, by infection with Chlamydia trachomatis or Chlamydia muridarum. Cell. Microbiol. 8: 1047-1057. *

• Woessner R, Grauer MT, Frese A, Bethke F, Ginger T, Hans A, Treib J 2006 Long-term antibiotic treatment with roxithromycin in patients with multiple sclerosis. Infection 34: 342-344.

• Xu Q 2003 Infections, heat shock proteins, and atherosclerosis. Curr. Opin. Cardiol. 18: 245-252.

• Yang T, Stark P, Janik K, Wigzell H, Rottenberg ME 2008 SOCS-1 protects against Chlamydia pneumoniae-induced lethal inflammation but hampers effective bacterial clearance. J. Immunol. 180: 4040-4049.

• Yang X, Coriolan D, Schultz K, Golenbock DT, Beasley D 2005 Toll-like receptor 2 mediates persistent chemokine release by Chlamydia pneumoniae-infected vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 25: 2308-2314. *

• Yu D, Kuipers JG 2003 Role of bacteria and HLA-B27 in the pathogenesis of reactive arthritis. Rheum. Dis. Clin. North Am. 29: 21-36, v-vi.

• Zeidler H, Kuipers J, Kohler L 2004 Chlamydia-induced arthritis. Curr. Opin. Rheumatol. 16: 380-392.

• Zeitz M, Ullrich R, Schneider T, Schieferdecker HL, Riecken EO 1994 Cell differentiation and proliferation in the gastrointestinal tract with respect to the local immune system. Ann. N. Y. Acad. Sci. 733: 75-86.

• Zhang X, Glogauer M, Zhu F, Kim TH, Chiu B, Inman RD 2005 Innate immunity and arthritis: neutrophil Rac and Toll-like receptor 4 expression define outcomes in infection-triggered arthritis. Arthritis Rheum. 52: 1297-1304. *

Number of references = 119

www psc-literature.org